MENU
VTGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

VistaGen Therapeutics (VTGN) Ownership - Who owns VistaGen Therapeutics?

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
343 Allerton Avenue
Phone
+1 650 577-3600
Employees
33
Web
https://www.vistagen.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
9.29M
P/E Ratio
N/A
Total Cash
61.77M
Projected Growth
N/A
Total Debt
1.43M
Revenue
789K
Risk (Beta)
0.32
Dividend Yield
N/A
Total Cash/Share
1.51
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price
View a ticker or compare two or three
VTGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of embryonic stem cells for drug discovery and development

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
343 Allerton Avenue
Phone
+1 650 577-3600
Employees
33
Web
https://www.vistagen.com